Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kim Kamdar Insider Profile
4 Followers
Kim Kamdar, Director at Evofem Biosciences, holds 0.00 shares in Evofem Biosciences (Ticker: EVFM), holds ― shares in Syndax Pharmaceuticals (Ticker: SNDX), holds 13.75K shares in Sera Prognostics (Ticker: SERA). Most recently, Kim Kamdar Sold ― shares of Evofem Biosciences on Dec 22, 2023 for an estimated value of 6.20.
Profitable Transactions
2 out of 6 Profitable Transactions
Average Return
-45.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kim Kamdar holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 15, 2023 - Aug 15, 2024
Return:+55.20%
The most profitable trade made by Kim Kamdar
Kim Kamdar's Trading History
Evofem Biosciences
Dec 22, 2023
Director
Informative Sell
6.20
$0.00
Syndax Pharmaceuticals
―
Director, Ten Percent Owner
―
―
ReShape Lifesciences
Aug 08, 2019
Director
Informative Buy
50.00K
$156.10K
Singular Genomics Systems
Aug 15, 2023
Director
Informative Sell
358.33K
$82.73M
Sera Prognostics
Jun 07, 2024
Director
Uninformative Buy
―
$91.00K
Clovis Oncology
Nov 15, 2011
―
Informative Buy
―
$491.37
Esperion
Jun 25, 2013
Ten Percent Owner
Informative Buy
―
$54.54K
Tobira Therapeutics
Aug 21, 2013
―
Informative Buy
―
$722.73K
Achillion Pharmaceuticals
Jan 17, 2012
―
Informative Buy
―
$169.00K
Zogenix
Jan 17, 2012
―
Informative Buy
―
$293.48K
Ocera Therapeutics
Jul 15, 2013
―
Informative Buy
―
$85.85K
Evoke Pharma
Sep 24, 2013
Ten Percent Owner
Informative Buy
―
$22.94K
Celator Pharmaceuticals
Jan 14, 2013
―
Informative Buy
―
$177.45K
Orexigen
Jan 17, 2012
―
Informative Buy
―
$9.81
Cadence Pharma
Mar 21, 2014
―
Uninformative Sell
385.00K
―
Durata
Jul 18, 2012
―
Informative Buy
―
―
List of latest transactions for each holding click on a transaction to see Kim Kamdar's performance on stock
You May Also Like
Kim Kamdar insider profile FAQ
What is the percentage of profitable transactions made by Kim Kamdar?
The percentage of profitable transactions made by Kim Kamdar is 33%.
What is the average return per transaction made by Kim Kamdar?
The average return per transaction made by Kim Kamdar is -45.10%.
What stocks does Kim Kamdar hold?
Kim Kamdar holds: EVFM, SNDX, RSLS, OMIC, SERA, CLVSQ, ESPR, TBRA, ~ACHN, ZGNX, OCRX, EVOK, CLPM, OREXQ, CADX, DRTX stocks.
What was Kim Kamdar’s latest transaction?
Kim Kamdar latest transaction was an Informative Sell of $6.20.
What was Kim Kamdar's most profitable transaction?
Kim Kamdar’s most profitable transaction was an Informative Sell of OMIC stock on August 15, 2023. The return on the trade was 55.20%.
What is Kim Kamdar's role in Evofem Biosciences?
Kim Kamdar's role in Evofem Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.